Health Condition 1: L910- Hypertrophic scar
Conditions
Interventions
Intervention1: Intralesional Steroid injections: Intralesional Steroid [triamcinolone acetonide 40mg/ml (vial: 40mg/ml)] with maximum dose of 2ml per session every 2 weeks for a maximum of five sessio
Sponsors
MGM Medical College and Hospital Aurangabad
Eligibility
Inclusion criteria
Inclusion criteria: 1.Keloid lesions present on trunk, upper limb, back. 2.Patients willing to undergo treatment and come for follow up.
Exclusion criteria
Exclusion criteria: 1.Patient with immunocompromised disorders. 2.Pregnant women & women who intend to become pregnant. 3.Patients with secondary infection at the site of lesion. 4.Patients who are already on systemic steroids. 5.Patients who are already on systemic verapamil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome for keloid and hypertrophic scars is assessed by Vancouver Scar Scale that records height, vascularization, pigmentation, pliability of the lesions and is used to quantify disease severity and response to treatment .Timepoint: The Assessment by Vancouver Scar Scale will be done every 15 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| reduced height of keloid and hypertrophic scars plaque is seen at day 45 and day 60Timepoint: day 45 and day 60 | — |
Countries
India
Contacts
Public ContactDr Ashish Deshmukh
MGM Medical College and Hospital Aurangabad
Outcome results
None listed